PPHE Hotel Group says its strategic review and formal sale process have progressed, with the Fattal proposal deemed not capable of delivery in its.....
Record Plc reported maintained ordinary dividends, stronger private markets momentum and a solid net asset position for the year ended 31 March 2026...
Tesco Plc said first-quarter sales grew, customer satisfaction improved and it continues to expect full-year adjusted operating profit of £3.0bn to £3.3bn...
Workspace Group has acknowledged a shareholder letter and presentation from Saba Capital Management and is reviewing both documents with its advisers...
Syncona reported annual results showing portfolio progress, capital deployment, valuation changes and a new investment policy focused on shareholder returns...
FGEN, a leading listed investment company with a diversified portfolio of environmental infrastructure assets across the UK and mainland Europe, announces its Annual Report.....
Cizzle Biotechnology has reached a pivotal commercial milestone, with its CIZ1B lung cancer blood test now available for clinical use in the United States. Executive Chairman Dr Allan Syms discusses..
PPHE Hotel Group says its strategic review and formal sale process have progressed, with the Fattal proposal deemed not capable of delivery in its.....
Record Plc reported maintained ordinary dividends, stronger private markets momentum and a solid net asset position for the year ended 31 March 2026...
Tesco Plc said first-quarter sales grew, customer satisfaction improved and it continues to expect full-year adjusted operating profit of £3.0bn to £3.3bn...
Workspace Group has acknowledged a shareholder letter and presentation from Saba Capital Management and is reviewing both documents with its advisers...
Syncona reported annual results showing portfolio progress, capital deployment, valuation changes and a new investment policy focused on shareholder returns...
FGEN, a leading listed investment company with a diversified portfolio of environmental infrastructure assets across the UK and mainland Europe, announces its Annual Report.....
Cizzle Biotechnology has reached a pivotal commercial milestone, with its CIZ1B lung cancer blood test now available for clinical use in the United States. Executive Chairman Dr Allan Syms discusses the royalty opportunity.....
